Mayne Pharma Group Ltd (MYX)

Sydney

Currency in AUD

MYX Pro Research

3.010

-0.010(-0.33%)

Closed·18/09

Fair Value

Unlock Value

Day's Range

2.960

3.020

52 wk Range

2.040

6.500

MYX Income Statement

Assess the Mayne Pharma income statement, providing a detailed view of the company’s financial performance across activities. This statement outlines key financial figures such as revenue, expenses, operating income, and net income. Assess the MYX net worth.

Period Ending:

2017

30/06

2018

30/06

2019

30/06

2020

30/06

2021

30/06

2022

30/06

2023

30/06

2024

30/06

2025

30/06

2026

30/06

Total Revenues

aa.aa

157.15

183.59

388.4

408.1

383.68

Total Revenues Growth

aa.aa

-60.79%

+16.82%

+111.56%

+5.07%

-5.98%

Cost Of Revenues

aa.aa

85.58

100.1

169.62

160.82

135.61

Gross Profit

aa.aa

71.57

83.49

218.78

247.27

248.07

Gross Profit Growth

aa.aa

-60.67%

+16.65%

+162.05%

+13.03%

+0.32%

Gross Profit Margin %

aa.aa

45.54%

45.48%

56.33%

60.59%

64.66%

Other Operating Expenses, Total

aa.aa

194.1

266.92

296.61

269.3

274.64

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-0.15%	+37.52%	+11.12%	-9.21%	+1.98%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	12.21	15.73	20.24	17.91	20.75
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	181.89	251.19	276.38	251.4	253.89
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-

Operating Income

aa.aa

-122.53

-183.43

-77.84

-22.03

-26.57

Operating Income Growth

aa.aa

-887.8%

-49.71%

+57.57%

+71.7%

-20.6%

EBIT Margin %

aa.aa

-77.97%

-99.92%

-20.04%

-5.4%

-6.92%

Net Interest Expenses

aa.aa

-10.24

-3.7

2.36

-0.1

-1.63

Net Interest Expenses Growth

aa.aa

+9.65%

+63.81%

+163.82%

-104.1%

-1,577.32%

Interest Expense, Total

aa.aa

-10.7

-10.42

-4.7

-5.01

-5.31

Interest And Investment Income

aa.aa

0.46

6.72

7.07

4.91

3.68

Other Non Operating Expenses, Total

aa.aa

-15.15

-23.49

-29.73

-30.94

-39.73

EBT, Excl. Unusual Items

aa.aa

-147.91

-210.63

-105.2

-53.07

-67.92

Gain (Loss) On Sale Of Assets

aa.aa

3.74

Other Unusual Items, Total

aa.aa

3.6

-46.92

-84

-28.6

108.42

EBT, Incl. Unusual Items

aa.aa

-145.59

-269.7

-190.09

-83.3

35.76

EBT, Incl. Unusual Items Growth

aa.aa

+44.83%

-85.25%

+29.52%

+56.18%

+142.93%

EBT, Incl. Unusual Items Margin

aa.aa

-92.64%

-146.91%

-48.94%

-20.41%

9.32%

Income Tax Expense

aa.aa

74.5

47.75

-21.47

6.78

4.56

Net Income to Company

aa.aa

-291.89

117.16

-174.23

-93.84

24.47

Minority Interest

aa.aa

10.61

0.09

Net Income

aa.aa

-281.29

117.25

-174.23

-93.84

24.47

Net Income Growth

aa.aa

-34.96%

+141.68%

-248.6%

+46.14%

+126.08%

Net Income Margin %

aa.aa

-179%

63.87%

-44.86%

-22.99%

6.38%

Preferred Dividend and Other Adjustments

aa.aa

Net Income to Common Excl. Extra Items

aa.aa

-209.48

-317.35

-168.62

-90.07

31.2

Basic EPS - Continuing Operations

aa.aa

-2.55

-3.86

-2.12

-1.14

0.39

Basic EPS - Continuing Operations Growth

aa.aa

+4.04%

-51.72%

+45.16%

+46.26%

+134.29%

Diluted EPS - Continuing Operations

aa.aa

-2.55

-3.86

-2.12

-1.14

0.27

Diluted EPS - Continuing Operations Growth

aa.aa

+3.87%

-51.44%

+45.1%

+46.23%

+123.76%

Basic Weighted Average Shares Outstanding

aa.aa

82.3

82.18

79.62

79.14

79.94

Diluted Weighted Average Shares Outstanding

aa.aa

82.3

82.18

79.62

79.14

106.29

Dividend Per Share

aa.aa

Dividend Per Share Growth

aa.aa

EBITDA

aa.aa

-46.34

-116.53

-14.5

42.08

33.11

EBITDA Growth

aa.aa

-192.6%

-151.48%

+87.55%

+390.13%

-21.32%

EBITDA Margin %

aa.aa

-29.49%

-63.48%

-3.73%

10.31%

8.63%

EBIT

aa.aa

-122.53

-183.43

-77.84

-22.03

-26.57

* In Millions of AUD (except for per share items)

FAQ

What was Mayne Pharma’s revenue at year end?

At the end of the last reported fiscal year, Mayne Pharma (MYX) recorded total revenue of 383.676 million AUD.

How much revenue did Mayne Pharma report in the most recent quarter?

In its most recent quarterly earnings report, Mayne Pharma posted revenue of 171.606 million AUD.

What was Mayne Pharma’s net income for the year?

For the full year, Mayne Pharma reported net income of 24.473 million AUD.

How much net income did Mayne Pharma post in the last quarter?

In the most recent quarter, Mayne Pharma (MYX) posted net income of 39.412 million AUD.

What was Mayne Pharma’s gross profit for the year?

Gross profit for the year was reported at 248.068 million AUD.

How much gross profit did Mayne Pharma generate last quarter?

Mayne Pharma recorded gross profit of 109.489 million AUD in its latest quarterly report.

What was Mayne Pharma’s annual operating income?

For the full year, Mayne Pharma (MYX) reported operating income of -26.569 million AUD.

What was Mayne Pharma’s operating income last quarter?

Quarterly operating income was -5.044 million AUD.

What was Mayne Pharma’s quarterly EBITDA?

In the latest quarter, EBITDA was reported at 22.922 million AUD.

What was the quarter-over-quarter change in EBITDA for Mayne Pharma?

EBITDA changed by 125.101% million AUD compared to the last quarter.

What is Mayne Pharma’s most recent gross profit margin?

The latest reported gross profit margin for Mayne Pharma (MYX) is 63.803% million AUD.

What is Mayne Pharma’s most recent net income margin?

Net income margin based on recent financials is 22.967% million AUD.

What is Mayne Pharma’s most recent EBIT margin?

Mayne Pharma reported an EBIT margin of -2.939% million AUD based on current figures.

How did Mayne Pharma’s revenue change compared to the previous quarter?

Revenue changed by -19.080% million AUD compared to the prior quarter.

What was the quarter-over-quarter change in gross profit for Mayne Pharma?

In the latest quarter, gross profit changed by -20.992% million AUD from the previous quarter.

S&P/TSX

35,806.65

-67.61

-0.19%

S&P/TSX 60

2,101.10

-7.37

-0.35%

US 30

51,733.00

-46.8

-0.09%

US 500

7,658.70

+21.0

+0.27%

S&P 500 VIX

14.81

-0.63

-4.08%

DAX

25,304.06

-412.65

-1.60%

Dollar Index

99.937

-0.048

-0.05%

Market Movers

Name	Last	Chg. %	Vol.
RBC	284.45	-0.17%	7.90M
Toronto Dominion Bank	171.48	+0.65%	12.53M
Canadian Natural	69.37	-2.06%	22.80M
Bank of Nova Scotia	131.63	-0.02%	8.99M
Enbridge	68.14	-0.06%	14.89M
Shopify Inc	179.34	-0.37%	5.51M
Canadian Imperial Bank	161.03	+1.24%	5.79M

Name	Last	Chg. %	Vol.
Lanebury Growth Capital	0.15	+200.00%	1.00K
1933 Industries	0.01	+200.00%	38.50K
Armada Mercantile Ltd	0.495	+120.00%	49.50K
Green Scientific Labs Holdings	0.06	+120.00%	15.00K
CardioComm Solutions Inc.	0.0100	+100.00%	133.04K
CordovaCann	0.0300	+100.00%	5.01K
1933 Industries	0.0100	+100.00%	38.50K

Name	Last	Chg. %	Vol.
Beckett’s	0.01	-100.00%	20.48K
Xigem Technologies	0.01	-66.67%	1.50K
Advance United Holdings	0.09	-63.27%	9.50K
ME Therapeutics Holdings	1.75	-57.32%	2.20K
ME Therapeutics Holdings	1.75	-57.32%	2.20K
Canadian Chrome A	0.35	-53.33%	1.00K
Volatus Capital	0.01	-50.00%	9.00K

Trending Stocks

Name	Last	Chg. %	Vol.
TELUS	12.31	-1.28%	22.03M
Toronto Dominion Bank	171.48	+0.65%	12.53M
Canadian Natural	69.37	-2.06%	22.80M
Whitecap Resources	18.86	+1.67%	14.75M
HIVE Digital Tech	4.7900	+10.11%	4.07M

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aa Aaaaaaaaaaa	97.01	+54.46%	149.84
Aaa Aaaaaaaa	7.92	+54.30%	12.22
Aaaaa Aaaa Aaaa A	114.16	+53.38%	175.10
Aaaaa A	2.3200	+51.37%	3.5118
Aaaaa Aaa A	31.53	+49.34%	47.09
Aaaa Aaaa Aaaaa	1.4300	+47.04%	2.1027
Aa Aa Aaa Aaaa	19.91	+44.29%	28.73

Name	Last	Upside	Fair Value
Aa Aaaaaaaaaaa	97.01	+54.46%	149.84
Aaa Aaaaaaaa	7.92	+54.30%	12.22
Aaaaa Aaaa Aaaa A	114.16	+53.38%	175.10
Aaaaa A	2.3200	+51.37%	3.5118
Aaaaa Aaa A	31.53	+49.34%	47.09
Aaaa Aaaa Aaaaa	1.4300	+47.04%	2.1027
Aa Aa Aaa Aaaa	19.91	+44.29%	28.73

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Popular Searches

Please try another search

Mayne Pharma Group Ltd (MYX)

MYX Income Statement

FAQ

What was Mayne Pharma’s revenue at year end?

How much revenue did Mayne Pharma report in the most recent quarter?

What was Mayne Pharma’s net income for the year?

How much net income did Mayne Pharma post in the last quarter?

What was Mayne Pharma’s gross profit for the year?

How much gross profit did Mayne Pharma generate last quarter?

What was Mayne Pharma’s annual operating income?

What was Mayne Pharma’s operating income last quarter?

What was Mayne Pharma’s quarterly EBITDA?

What was the quarter-over-quarter change in EBITDA for Mayne Pharma?

What is Mayne Pharma’s most recent gross profit margin?

What is Mayne Pharma’s most recent net income margin?

What is Mayne Pharma’s most recent EBIT margin?

How did Mayne Pharma’s revenue change compared to the previous quarter?

What was the quarter-over-quarter change in gross profit for Mayne Pharma?

Trending Stocks